The bad news about Avandia's association with heart attack has been good news for Takeda, the maker of Actos. Both drugs are thiazolidinediones (TZD). They help lower blood sugar by reducing insulin resistance. Until the ACCORD study results came out last year, Avandia was prescribed far more frequently than Actos. Now, with Avandia's reputation in tatters, Takeda has been pushing doctors to
